Modern Warrior Recalls Modern Warrior Ready Dietary Supplement Over Undeclared Drug Ingredients

PHOENIX, AZ (January 9, 2026) — The U.S. Food and Drug Administration (FDA) has announced that Modern Warrior is voluntarily recalling all lots of its Modern Warrior Ready dietary supplement after regulators confirmed the product contains undeclared drug ingredients, including tianeptine, 1,4-DMAA, and aniracetam. As a result, the FDA said it has not approved these substances for use in dietary supplements and warned that they pose serious health risks to consumers.

Regulators issued the recall after regulatory testing identified the unapproved compounds in capsules marketed for metabolism boosting, cognitive improvement, and craving reduction. The agency confirmed that the company sold the product nationwide through online channels for more than two years.

Modern Warrior recall: quick summary

The FDA said Modern Warrior initiated the recall after testing found unapproved and undeclared drug ingredients in a product sold as a dietary supplement. Modern Warrior distributed the recalled product, Modern Warrior Ready, nationwide through online sales between April 2022 and December 8, 2025. The FDA advises consumers to stop using the product immediately due to potentially life-threatening risks associated with tianeptine and cardiovascular effects linked to 1,4-DMAA. The company has ceased distribution and quarantined the remaining inventory.

What happened?

The FDA said Modern Warrior initiated the recall after regulatory testing identified undeclared ingredients that classified the product as an unapproved new drug. The company announced the recall on January 9, 2026, in coordination with the FDA.

According to the company, Modern Warrior told regulators that it identified the issue during a regulatory review, which detected tianeptine (a substance not approved for use in dietary supplements), along with 1,4-DMAA and aniracetam, neither of which appeared on the product label.

In response, the FDA warned in its recall alert that “tianeptine can cause life-threatening events, including suicidal ideation or behavior, particularly in younger consumers,” and linked the use of 1,4-DMAA to elevated blood pressure and serious cardiovascular complications.

During the affected period, Modern Warrior sold the product nationwide through online channels from April 2022 until December 8, 2025.

Affected products

Brand	Product	Size	Best by date	Issue	Affected areas
Modern Warrior	Modern Warrior Ready	60 capsules	All lots	Undeclared drugs	Nationwide (online)

What caused the issue?

According to the FDA notice, the presence of undeclared active pharmaceutical ingredients in a product marketed as a dietary supplement prompted the recall. Specifically, the agency confirmed that tianeptine poses risks including seizures, respiratory distress, and mental health effects. Meanwhile, the FDA said 1,4-DMAA increases the risk of heart attack and stroke. The FDA considers young adults, people with cardiovascular conditions, and individuals taking antidepressants to be most at risk. The agency reported no illnesses as of the announcement date.

Questions you might have

Here’s what you should do

• Stop using the product immediately
• Check the label for “Modern Warrior Ready – Mental Clarity,” 60 capsules
• Do not dispose of the product without guidance; contact the company first
• Consumer contact: (314) 713-1984 or [email protected]

Behind the brand

Modern Warrior is a supplement brand that sells products directly to consumers online, positioning itself around performance and mental clarity. In its recall notice, the company stated it has ceased distribution, removed the product from sale, and quarantined remaining inventory. Source86 reached out to Modern Warrior for additional comment on how the issue occurred, but has not yet received a response.

Other relevant recalls

This recall follows a broader pattern of FDA enforcement actions involving dietary supplements that pose serious health risks, particularly products containing undeclared drugs or dangerous contaminants. In recent months, for example, the FDA has taken action on several supplement-related safety concerns, including Silintan’s recall of dietary supplement capsules after discovering undeclared meloxicam, as well as Purity Products’ recall of its MyBladder dietary supplement due to possible E. coli contamination. Additionally, the agency issued a warning after investigators found toxic Yellow Oleander in weight loss supplements sold to U.S. consumers. Together, these cases highlight persistent gaps in ingredient verification, testing, and regulatory compliance within certain segments of the supplement industry.

“Dietary supplements are regulated as a category of food, and the FDA does not evaluate new dietary supplements for safety and effectiveness before they are sold to consumers. Products that contain hidden pharmaceutical ingredients and are marketed as supplements put consumers at risk, especially when they interact with medications or underlying health conditions,” said the U.S. Food and Drug Administration in its consumer guidance on dietary supplements.

Eran Mizrahi, CEO of Source86, said the incident underscores a larger industry challenge:

“Food safety isn’t just about compliance; it’s about trust. Transparency and supplier accountability are essential.”

Ensuring safe eats

This recall highlights ongoing concerns around dietary supplement oversight and the importance of rigorous testing and transparent labeling. Consumers should follow recall guidance closely, while companies must strengthen supplier verification and quality controls.

At Source86, we support brands with bulk ingredient sourcing, private label services, and FSQA oversight to help prevent issues like this and respond quickly when recalls occur. Contact us.